Department of Surgery, University Hospital Basel, 4031 Basel, Switzerland.
Eur J Surg Oncol. 2010 Jul;36(7):670-7. doi: 10.1016/j.ejso.2010.05.012. Epub 2010 May 26.
Tumor-infiltrating lymphocytes (TILs) and forkhead box transcription factor positive (FoxP3(+)) regulatory T-lymphocytes (TREGs) have been analyzed in a variety of tumors but not in oesophageal adenocarcinoma.
Tissue from 130 adenocarcinomas of the oesophagus was re-evaluated in the centre and periphery of tumour, respectively, using immunohistochemical staining with anti-CD3, anti-CD4, anti-CD8, anti-CD25 and anti-FoxP3 antibodies. Patients were stratified according neoadjuvant treatment. 106 patients proceeded directly to surgery and 24 underwent pre-operative radio-chemotherapy (RCT).
In patients without RCT, TILs were found significantly more frequently in the periphery with the exception of CD25(+) cells. Patients with centrally low counts of FoxP3(+) TREGs had higher tumour stages than patients with high counts (p < 0.011). The number of FoxP3(+) TREGs was significantly associated with the number of CD8(+) cells (centre: p < 0.001, periphery: p = 0.002). The multivariate regression analysis identified UICC stage (IIB/III vs. I/IIA, hazard ratio 2.6, p = 0.011) and completeness of resection (no vs. yes, hazard ratio 2.3, p = 0.015) as independent predictors of survival. RCT significantly reduced the number of TREGs in the centre (p = 0.016) but not the number of the other TILs.
UICC stage and completeness of resection but none of the TILs were prognostic markers for long-term survival. We found no morphologic evidence that TREGs suppress immunological response, represented by the infiltration of CD8(+) cells. Preoperative RCT affected the centre of tumours more than the periphery, which may indicate that it does not inhibit the host-to-tumour reaction. RCT affects TREGs more than the other TILs.
肿瘤浸润淋巴细胞(TILs)和叉头框转录因子阳性(FoxP3(+))调节性 T 淋巴细胞(TREGs)已在多种肿瘤中进行了分析,但尚未在食管腺癌中进行分析。
在中心和肿瘤外围分别使用抗 CD3、抗 CD4、抗 CD8、抗 CD25 和抗 FoxP3 抗体的免疫组织化学染色对 130 例食管腺癌组织进行重新评估。根据新辅助治疗对患者进行分层。106 例患者直接手术,24 例患者接受术前放化疗(RCT)。
在未接受 RCT 的患者中,除 CD25(+)细胞外,TILs 在肿瘤外围的检出频率明显更高。FoxP3(+)TREG 计数低的中心患者的肿瘤分期高于 FoxP3(+)TREG 计数高的患者(p < 0.011)。FoxP3(+)TREG 数量与 CD8(+)细胞数量显著相关(中心:p < 0.001,外围:p = 0.002)。多变量回归分析确定 UICC 分期(IIB/III 期与 I/IIA 期,风险比 2.6,p = 0.011)和切除完整性(无 vs. 是,风险比 2.3,p = 0.015)是生存的独立预测因子。RCT 显著降低了中心的 TREG 数量(p = 0.016),但对其他 TIL 数量没有影响。
UICC 分期和切除完整性但不是任何 TIL 都是长期生存的预后标志物。我们没有发现形态学证据表明 TREG 抑制免疫反应,代表 CD8(+)细胞的浸润。术前 RCT 对肿瘤中心的影响大于肿瘤外围,这可能表明它不会抑制宿主对肿瘤的反应。RCT 对 TREG 的影响大于其他 TIL。